U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION: FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. Read More »